期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 61, 期 15, 页码 6869-6891出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.8b00808
关键词
-
EP2 receptor agonists are expected to be effective ocular hypotensive agents; however, it has been suggested that agonism to other EP receptor subtypes may lead to undesirable effects. Through medicinal chemistry efforts, we identified a scaffold bearing a (pyridin-2-ylamino)-acetic acid moiety as a promising EP2-selective receptor agonist. (64(4-(Pyrazol-1-yl)benzyl)(pyridin-3-ylsulfonyl)-aminomethyppyridin-2-ylamino)acetic acid 13ax (omidenepag, OMD) exerted potent and selective human EP2 receptor (h-EP2). Low doses of omidenepag isopropyl (OMDI), a prodrug of 13ax, lowered (IOP) in ocular normotensive monkeys. OMDI was selected as a clinical candidate for the treatment of glaucoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据